Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell Carcinoma
Collectively, we show that serial ctDNA monitoring provides prognostic information for patients undergoing treatment or surveillance, and our findings demonstrate high concordance between ctDNA status/dynamics and subsequent clinical outcomes.
Authors
- Hyndavi Kandala
- Carcia Carson (ORCID: https://orcid.org/0000-0003-3424-695X)
- Cherry Au (ORCID: https://orcid.org/0000-0002-8483-0647)
- Arnab Basu (ORCID: https://orcid.org/0000-0002-8678-3880)
- Minetta C. Liu (ORCID: https://orcid.org/0000-0002-8206-5232)
- Tamara Mahmood
- Sumedha Sudhaman (ORCID: https://orcid.org/0000-0001-9266-7096)
- Meenakshi Malhotra (ORCID: https://orcid.org/0000-0002-9731-5628)
- Adam C. ElNaggar (ORCID: https://orcid.org/0000-0003-3409-583X)
- Charles C. Peyton (ORCID: https://orcid.org/0000-0003-0869-7431)
- James E. Ferguson (ORCID: https://orcid.org/0000-0001-9073-9615)
- Soroush Rais‐Bahrami (ORCID: https://orcid.org/0000-0001-9466-9925)
- Mark Calhoun (ORCID: https://orcid.org/0000-0002-2033-2075)
- Natalia Pajak
- Ajitha Kommalapati
- Punashi Dutta (ORCID: https://orcid.org/0000-0002-5963-7212)
- Alan Tan (ORCID: https://orcid.org/0000-0002-6350-5917)
Institutions
- Rush University Medical Center (US)
- University of Alabama at Birmingham (US)
- Natera (United States) (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- JCO Precision Oncology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1200/po-24-00667
- Citations
- 12
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 3.42